Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Buch, M. H., Burmester, G. R., … van der Heijde, D. (2022). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), 3–18. https://doi.org/10.1136/ard-2022-223356
Subjects:
Antirheumatic Agents
(MeSH)
Biosimilar Pharmaceuticals
(MeSH)
Arthritis, Rheumatoid
(MeSH)
Neoplasms
(MeSH)
Biological Products
(MeSH)
Publication Type:
Article
Unique ID:
10.1136/ard-2022-223356
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: